	Re-evaluating the Role of Whole Brain Radiotherapy for Brain Metastases From Non-small Cell Lung Cancer in the Immunotherapy Era: A Retrospective Cohort Study. Cureus Forster P. PMID: 42500752 [PubMed]
	Delafloxacin suppresses DEPDC1 expression and induces G2/M arrest in non-small cell lung cancer cells: A drug repurposing study. Smart Mol Ali N, Shafiq F, Iftikhar M, Zafar MS, Shoaib M. PMID: 42500733 [PubMed - as supplied by publisher]
	Enhanced through-bond energy transfer-based bioorthogonal probe enables catalytic-amplified and sensitive detection of microRNA-21 for clinical lung cancer diagnosis. Smart Mol Li Y, Han F, Huang H, Zhou D, Long S, Sun W, Du J, Fan J, Ning J, Peng C, Peng X. PMID: 42500706 [PubMed - as supplied by publisher]
	Cancer Drug Development in Never-Smoker Lung Cancer: Targeted and Immune-Based Therapeutic Strategies. Oncol Res Cojocaru C, Costuleanu M, Petri, Cojocaru R, Vasîncu D, Cojocaru E. PMID: 42500583 [PubMed - indexed for MEDLINE]
	GPX4 Defines an Immune-Cold Phenotype and Poor Prognosis in Resected Lung Adenocarcinoma. Oncol Res Wang G, Liu Z, Zhou T, Yang B, Chen J, Chen J, Huang K, Xu Y, Tang Q, Yin X, Xiao G, Zhang S. PMID: 42500575 [PubMed - indexed for MEDLINE]
	ANLN: A New Hub in Glutamine Metabolism of Lung Adenocarcinoma by scRNA-Seq and Machine Learning. Oncol Res Ma Y, Zhang Z, Pan H, Jiang H, Guo L, Guo F. PMID: 42500572 [PubMed - indexed for MEDLINE]
	Effect of high-intensity interval training on clinical outcomes in lung cancer patients undergoing surgery: a meta-analysis based on randomized controlled trials. Front Med (Lausanne) Li D, Chen H, Zuo Q, Lv F, Shen K, Sun M. PMID: 42500527 [PubMed]
	Nomogram integrating MRI radiomics and white matter hyperintensity grading for predicting overall survival in patients with non-small cell lung cancer and brain metastases receiving whole-brain radiotherapy. Precis Radiat Oncol Ni J, Lu Y, Xu H, Xu X, Zhao M, Xue Y, Li G, Duan Y. PMID: 42500423 [PubMed - as supplied by publisher]
	Real-world evidence of baseline soluble CD25 as a prognostic biomarker and indicator of differential EGFR-TKI benefit in stage IV lung adenocarcinoma. Front Oncol Guo H, Liu L, Lindberg V, Xue Y, Baak JPA. PMID: 42500294 [PubMed]
	Cost-effectiveness analysis of first-line gefitinib plus anlotinib treatment for patients with stage IIIB-IV EGFR-mutated NSCLC in China. Front Public Health Chen P, Jiang Y, Chen Y, Luo S, Wu C, Tang Q, Zhang D, Wang Y, Ma J. PMID: 42500005 [PubMed - indexed for MEDLINE]
	Effect of programmed cell death protein-1 inhibitor combined with platinum-containing dual-agent chemotherapy regimen on gut microbiota in Lewis lung cancer model mice. Front Microbiol Dai L, Kong FL. PMID: 42499661 [PubMed]
	Efficacy and prognostic factors of first-line bevacizumab plus chemotherapy in elderly patients with advanced driver gene-negative lung adenocarcinoma: A retrospective study. Medicine (Baltimore) Li S, Wang S, Cao R. PMID: 42499069 [PubMed - indexed for MEDLINE]
	Personalized tumor-loaded monocyte-derived dendritic cell vaccination in combination with atezolizumab as maintenance treatment in extensive-stage small cell lung cancer (ES-SCLC): phase Ib-II VENEZOLUNG trial. J Immunother Cancer Gonzalez-Cao M, Sisteré-Oró M, Moran T, Reguart N, Cabezon R, Aguilar Hernández A, Roman R, Molina-Vila MA, Birgin K, Domenjo-Vila E, Piqué G, Lozano M, Charry P, Reyes R, Moya I, Cirera L, Esparre C, Drozdowskyj A, Martínez Pérez E, Rosell R, Juan M, Meyerhans A, Benitez-Ribas D. PMID: 42498486 [PubMed - indexed for MEDLINE]
	Sinonasal NUT carcinoma mimicking acute ethmoiditis. BMJ Case Rep Mughal HA, Jørgensen MM, Krone W, Darling P. PMID: 42498315 [PubMed - indexed for MEDLINE]
	Diet-induced obesity fails to prime tumour-associated neuroinflammation in mice with Lewis Lung Carcinoma. Neuroscience Fowler CG, Rodriguez R, Beaudry AG, Kusumo LE, Gillett AE, Wiggs MP, Law ML, Vichaya EG. PMID: 42498066 [PubMed - as supplied by publisher]
	Multicenter retrospective study on the clinical profiles of patients with extensive-stage small-cell lung cancer who met the eligibility criteria for clinical trials. Curr Probl Cancer Yazaki T, Sonehara K, Tsutsui T, Nozawa S, Agatsuma T, Yamamoto M, Matsuo A, Nakanishi M, Chiaki T, Kato A, Miyahara T, Hachiya T, Kanda S, Hanaoka M. PMID: 42497812 [PubMed - as supplied by publisher]
	Impact of immunotherapy on overall survival and healthcare costs in advanced/metastatic lung cancer: A real-world study in France. Lung Cancer Rousseau A, Foix-Colonier A, Luu J, Foulon S, Besse B, Valentine Laizet V, Jewiti-Rigondza KJ, Sidhom A, Nacef N, Gauthier A, Monia Ezzalfani M, Bonastre J. PMID: 42497525 [PubMed - as supplied by publisher]
	Basic and Translational Research Advances in NSCLC. Cancer J Sharma R, Politi K. PMID: 42497399 [PubMed - indexed for MEDLINE]
	Medical Management of Non-Small Cell Lung Cancer Brain Metastases in the Modern Era. Cancer J Lu BY, Goldberg SB. PMID: 42497398 [PubMed - indexed for MEDLINE]
	Optimizing the Care of Patients With Locally Advanced NSCLC With Multimodality Therapy. Cancer J Mohammed M, McCall NS, Higgins KA. PMID: 42497397 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 161772

Page 1 of 8089



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy